Thioredoxin Systems AB (TXN Systems) is a pharmaceutical company focused on developing EbsArgent™, a first-in-class bactericidal antibiotic designed to treat urinary tract infections caused by multidrug-resistant bacteria. The company's innovative approach targets a critical need in combating antibiotic resistance, aiming to provide effective solutions for challenging infections.
Leadership & Board
Current Number of Employees8
Current LinkedIn Followers296
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$25M
Total Amount Raised$25M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$25M
Latest Funding Amount$25M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Thioredoxin Systems AB (TXN Systems) had 8 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
8Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Thioredoxin Systems AB (TXN Systems) had 296 followers as of October 5, 2026. The number of followers decreased by 1 (0.34%) week-over-week.
296Latest Followers Count
1(-0.34%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.